Molecular mechanisms and imaging of lymphatic metastasis

Experimental Cell Research

Volumn 319, Issue 11, 2013, Pages 1611-1617

  Proulx, Steven T ^a   Detmar, Michael ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Imaging; Lymphatic vessels; Metastasis; Tumor

Indexed keywords

STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CARCINOGENESIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GOLD STANDARD; HUMAN; HYPOTHESIS; LYMPHANGIOGENESIS; LYMPHANGIOGRAPHY; LYMPHATIC DRAINAGE; LYMPHEDEMA; LYMPHOSCINTIGRAPHY; MOLECULAR IMAGING; MOLECULAR PATHOLOGY; MORBIDITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOACOUSTIC SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENTINEL LYMPH NODE METASTASIS; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR CELL; X RAY;

IMAGING; LYMPHATIC VESSELS; METASTASIS; TUMOR;

ANIMALS; DIAGNOSTIC IMAGING; HUMANS; LYMPHATIC METASTASIS; NEOPLASMS;

EID: 84879605346     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.03.009     Document Type: Review

References (61)

1. Leong S.P., Zuber M., Ferris R.L., Kitagawa Y., Cabanas R., Levenback C., Faries M., Saha S. Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients. J. Surg. Oncol. 2011, 103:518-530.
2. Veenstra H.J., Wouters M.W., Kroon B.B., Olmos R.A., Nieweg O.E. Less false-negative sentinel node procedures in melanoma patients with experience and proper collaboration. J. Surg. Oncol. 2011, 104:454-457.
3. Vidal-Sicart S., Valdes Olmos R. Sentinel node mapping for breast cancer: current situation. J. Oncol. 2012, 2012:361341.
4. Ross G.L., Soutar D.S., Gordon MacDonald D., Shoaib T., Camilleri I., Roberton A.G., Sorensen J.A., Thomsen J., Grupe P., Alvarez J., Barbier L., Santamaria J., Poli T., Massarelli O., Sesenna E., Kovacs A.F., Grunwald F., Barzan L., Sulfaro S., Alberti F. Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann. Surg. Oncol. 2004, 11:690-696.
5. Tanis P.J., Lont A.P., Meinhardt W., Olmos R.A., Nieweg O.E., Horenblas S. Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J. Urol. 2002, 168:76-80.
6. de Hullu J.A., Hollema H., Piers D.A., Verheijen R.H., van Diest P.J., Mourits M.J., Aalders J.G., van Der Zee A.G. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J. Clin. Oncol. 2000, 18:2811-2816.
7. Loukas M., Bellary S.S., Kuklinski M., Ferrauiola J., Yadav A., Shoja M.M., Shaffer K., Tubbs R.S. The lymphatic system: a historical perspective. Clin. Anat. 2011, 24:807-816.
8. Tanis P.J., Nieweg O.E., Valdes Olmos R.A., Th Rutgers E.J., Kroon B.B. History of sentinel node and validation of the technique. Breast Cancer Res. 2001, 3:109-112.
9. Halsted W.S. I. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann. Surg. 1894, 20:497-555.
10. Fisher B., Fisher E.R. Barrier function of lymph node to tumor cells and erythrocytes I. normal nodes. Cancer 1967, 20:1907-1913.
11. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J. Clin. Oncol. 1994, 12:2229-2234.
12. Punglia R.S., Morrow M., Winer E.P., Harris J.R. Local therapy and survival in breast cancer. N. Engl. J. Med. 2007, 356:2399-2405.
13. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 1977, 39:456-466.
14. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., Foshag L.J., Cochran A.J. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 1992, 127:392-399.
15. Alex J.C., Krag D.N. Gamma-probe guided localization of lymph nodes. Surg. Oncol. 1993, 2:137-143.
16. Goyal A., Newcombe R.G., Chhabra A., Mansel R.E. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast. Cancer Res. Treat. 2006, 99:203-208.
17. Kroon B.K., Horenblas S., Estourgie S.H., Lont A.P., Valdes Olmos R.A., Nieweg O.E. How to avoid false-negative dynamic sentinel node procedures in penile carcinoma. J. Urol. 2004, 171:2191-2194.
18. Porter G.A., Ross M.I., Berman R.S., Lee J.E., Mansfield P.F., Gershenwald J.E. Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann. Surg. Oncol. 2000, 7:256-261.
19. Leijte J.A., van der Ploeg I.M., Valdes Olmos R.A., Nieweg O.E., Horenblas S. Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J. Nucl. Med. 2009, 50:364-367.
20. Alitalo K. The lymphatic vasculature in disease. Nat. Med. 2011, 17:1371-1380.
21. Martinez-Corral I., Makinen T. Regulation of lymphatic vascular morphogenesis: implications for pathological (tumor)lymphangiogenesis. Exp. Cell Res. 2013.
22. Skobe M., Hawighorst T., Jackson D.G., Prevo R., Janes L., Velasco P., Riccardi L., Alitalo K., Claffey K., Detmar M. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 2001, 7:192-198.
23. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., Banerji S., Huarte J., Montesano R., Jackson D.G., Orci L., Alitalo K., Christofori G., Pepper M.S. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 2001, 20:672-682.
24. Stacker S.A., Caesar C., Baldwin M.E., Thornton G.E., Williams R.A., Prevo R., Jackson D.G., Nishikawa S., Kubo H., Achen M.G. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 2001, 7:186-191.
25. Shin J.W., Min M., Larrieu-Lahargue F., Canron X., Kunstfeld R., Nguyen L., Henderson J.E., Bikfalvi A., Detmar M., Hong Y.K. Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol. Biol. Cell 2006, 17:576-584.
26. Kajiya K., Hirakawa S., Ma B., Drinnenberg I., Detmar M. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J. 2005, 24:2885-2895.
27. Rinderknecht M., Detmar M. Tumor lymphangiogenesis and melanoma metastasis. J. Cell Physiol. 2008, 216:347-354.
28. Dadras S.S., Lange-Asschenfeldt B., Velasco P., Nguyen L., Vora A., Muzikansky A., Jahnke K., Hauschild A., Hirakawa S., Mihm M.C., Detmar M. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod. Pathol. 2005, 18:1232-1242.
29. Schoppmann S.F., Birner P., Stockl J., Kalt R., Ullrich R., Caucig C., Kriehuber E., Nagy K., Alitalo K., Kerjaschki D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am. J. Pathol. 2002, 161:947-956.
30. Hirakawa S., Brown L.F., Kodama S., Paavonen K., Alitalo K., Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007, 109:1010-1017.
31. Hirakawa S., Kodama S., Kunstfeld R., Kajiya K., Brown L.F., Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 2005, 201:1089-1099.
32. Mumprecht V., Detmar M. Lymphangiogenesis and cancer metastasis. J. Cell Mol. Med. 2009, 13:1405-1416.
33. Halin C., Tobler N.E., Vigl B., Brown L.F., Detmar M. VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 2007, 110:3158-3167.
34. Harrell M.I., Iritani B.M., Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol. 2007, 170:774-786.
35. Van den Eynden G.G., Vandenberghe M.K., van Dam P.J., Colpaert C.G., van Dam P., Dirix L.Y., Vermeulen P.B., Van Marck E.A. Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin. Cancer Res. 2007, 13:5391-5397.
36. Proulx S.T., Luciani P., Derzsi S., Rinderknecht M., Mumprecht V., Leroux J.C., Detmar M. Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res. 2010, 70:7053-7062.
37. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E., Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
38. Norrmen C., Ivanov K.I., Cheng J., Zangger N., Delorenzi M., Jaquet M., Miura N., Puolakkainen P., Horsley V., Hu J., Augustin H.G., Yla-Herttuala S., Alitalo K., Petrova T.V. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J. Cell. Biol. 2009, 185:439-457.
39. Lahdenranta J., Hagendoorn J., Padera T.P., Hoshida T., Nelson G., Kashiwagi S., Jain R.K., Fukumura D. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis. Cancer Res. 2009, 69:2801-2808.
40. Karnezis T., Shayan R., Caesar C., Roufail S., Harris N.C., Ardipradja K., Zhang Y.F., Williams S.P., Farnsworth R.H., Chai M.G., Rupasinghe T.W., Tull D.L., Baldwin M.E., Sloan E.K., Fox S.B., Achen M.G., Stacker S.A. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 2012, 21:181-195.
41. Kinmonth J.B. Lymphangiography in man; a method of outlining lymphatic trunks at operation. Clin. Sci. (Lond.) 1952, 11:13-20.
42. Barrett T., Choyke P.L., Kobayashi H. Imaging of the lymphatic system: new horizons. Contrast Media Mol. Imaging 2006, 1:230-245.
43. Modi S., Stanton A.W., Mortimer P.S., Levick J.R. Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: a critical review of lymphoscintigraphy. Lymph. Res. Biol. 2007, 5:183-202.
44. Sevick-Muraca E.M. Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu. Rev. Med. 2012, 63:217-231.
45. Kim S., Lim Y.T., Soltesz E.G., De Grand A.M., Lee J., Nakayama A., Parker J.A., Mihaljevic T., Laurence R.G., Dor D.M., Cohn L.H., Bawendi M.G., Frangioni J.V. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 2004, 22:93-97.
46. Proulx S.T., Luciani P., Alitalo A., Mumprecht V., J., Huggenberger C.A., Leroux R., J.C., Detmar M. Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo. Angiogenesis 2013, 10.1007/s10456-013-9332-2.
47. Schaafsma B.E., Mieog J.S., Hutteman M., van der Vorst J.R., Kuppen P.J., Lowik C.W., Frangioni J.V., van de Velde C.J., Vahrmeijer A.L. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J. Surg. Oncol. 2011, 104:323-332.
48. Song K.H., Kim C., Cobley C.M., Xia Y., Wang L.V. Near-infrared gold nanocages as a new class of tracers for photoacoustic sentinel lymph node mapping on a rat model. Nano Lett. 2009, 9:183-188.
49. Pan D., Cai X., Kim B., Stacy A.J., Wang L.V., Lanza G.M. Rapid synthesis of near infrared polymeric micelles for real-time sentinel lymph node imaging. Adv. Healthcare. Mater. 2012, 1:582-589.
50. Kobayashi H., Kawamoto S., Bernardo M., Brechbiel M.W., Knopp M.V., Choyke P.L. Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J. Control Release 2006, 111:343-351.
51. Vermeeren L., Valdes Olmos R.A., Meinhardt W., Bex A., van der Poel H.G., Vogel W.V., Sivro F., Hoefnagel C.A., Horenblas S. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J. Nucl. Med. 2009, 50:865-870.
52. Stoffels I., Boy C., Poppel T., Kuhn J., Klotgen K., Dissemond J., Schadendorf D., Klode J. Association between sentinel lymph node excision with or without preoperative SPECT/CT and metastatic node detection and disease-free survival in melanoma. JAMA 2012, 308:1007-1014.
53. Mumprecht V., Honer M., Vigl B., Proulx S.T., Trachsel E., Kaspar M., Banziger-Tobler N.E., Schibli R., Neri D., Detmar M. In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography. Cancer Res. 2010, 70:8842-8851.
54. Thorek D.L., Abou D.S., Beattie B.J., Bartlett R.M., Huang R., Zanzonico P.B., Grimm J. Positron lymphography: multimodal, high-resolution, dynamic mapping and resection of lymph nodes after intradermal injection of 18F-FDG. J. Nucl. Med. 2012, 53:1438-1445.
55. Laakkonen P., Porkka K., Hoffman J.A., Ruoslahti E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 2002, 8:751-755.
56. Tafreshi N.K., Bui M.M., Bishop K., Lloyd M.C., Enkemann S.A., Lopez A.S., Abrahams D., Carter B.W., Vagner J., Grobmyer S.R., Gillies R.J., Morse D.L. Noninvasive detection of breast cancer lymph node metastasis using carbonic anhydrases IX and XII targeted imaging probes. Clin. Can. Res. 2012, 18:207-219.
57. Emerson D.K., Limmer K.K., Hall D.J., Han S.H., Eckelman W.C., Kane C.J., Wallace A.M., Vera D.R. A receptor-targeted fluorescent radiopharmaceutical for multireporter sentinel lymph node imaging. Radiology 2012, 265:186-193.
58. Dadras S.S., Paul T., Bertoncini J., Brown L.F., Muzikansky A., Jackson D.G., Ellwanger U., Garbe C., Mihm M.C., Detmar M. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am. J. Pathol. 2003, 162:1951-1960.
59. Tammela T., Saaristo A., Holopainen T., Yla-Herttuala S., Andersson L.C., Virolainen S., Immonen I., Alitalo K. Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis. Sci. Transl. Med. 2011, 3. 69ra11.
60. Nune S.K., Gunda P., Majeti B.K., Thallapally P.K., Forrest M.L. Advances in lymphatic imaging and drug delivery. Adv. Drug. Deliv. Rev. 2011, 63:876-885.
61. Rockson S.G. Diagnosis and management of lymphatic vascular disease. J. Am. Coll. Cardiol. 2008, 52:799-806.